资讯

来自MSN2 分钟
ASCO25: Genmab’s Rina-S en route to ‘blockbuster potential’ amid further positive data
Genmab’s antibody drug conjugate (ADC) rinatabart sesutecan (Rina-S) demonstrated positive efficacy in treating patients with ...